v3.24.2.u1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2022   225,200,000        
Balance at beginning of period at Dec. 31, 2022 $ 3,961 $ 2 $ 3,036 $ 1,010 $ (14) $ (73)
Treasury stock, common, beginning balance (in shares) at Dec. 31, 2022         400,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 14   14      
Proceeds from employee stock purchase plan (in shares)   200,000        
Proceeds from employee stock purchase plan 5   5      
Vested restricted stock units, net (in shares)   600,000        
Exercise of stock options (in shares)   300,000        
Exercise of stock options 7   7      
Tax withholding payments for net share-settled equity awards (11)   (11)      
Series A convertible preferred stock conversion to common stock (in shares)   7,600,000        
Series A convertible preferred stock conversion to common stock 161   161      
Series A convertible preferred stock dividends (7)     (7)    
Changes in retirement benefit obligations, net of income tax 1         1
Common stock repurchased (in shares)         900,000  
Common stock repurchased (34)       $ (34)  
Net income 82     82    
Common stock outstanding, ending balance (in shares) at Apr. 01, 2023   233,900,000        
Balance at end of period at Apr. 01, 2023 4,179 $ 2 3,212 1,085 $ (48) (72)
Treasury stock, common, ending balance (in shares) at Apr. 01, 2023         1,300,000  
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2022   225,200,000        
Balance at beginning of period at Dec. 31, 2022 3,961 $ 2 3,036 1,010 $ (14) (73)
Treasury stock, common, beginning balance (in shares) at Dec. 31, 2022         400,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Changes in retirement benefit obligations, net of income tax 1          
Net income 264          
Common stock outstanding, ending balance (in shares) at Jul. 01, 2023   252,300,000        
Balance at end of period at Jul. 01, 2023 4,604 $ 3 3,621 1,267 $ (216) (71)
Treasury stock, common, ending balance (in shares) at Jul. 01, 2023         5,500,000  
Common stock outstanding, beginning balance (in shares) at Apr. 01, 2023   233,900,000        
Balance at beginning of period at Apr. 01, 2023 4,179 $ 2 3,212 1,085 $ (48) (72)
Treasury stock, common, beginning balance (in shares) at Apr. 01, 2023         1,300,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 14   14      
Proceeds from employee stock purchase plan (in shares)   200,000        
Proceeds from employee stock purchase plan 8   8      
Vested restricted stock units, net (in shares)   100,000        
Exercise of stock options (in shares)   700,000        
Exercise of stock options 15   15      
Series A convertible preferred stock conversion to common stock (in shares)   17,400,000        
Series A convertible preferred stock conversion to common stock 373 $ 1 372      
Unrecognized gain on interest rate caps, net of income tax (1)         (1)
Changes in retirement benefit obligations, net of income tax 0          
Common stock repurchased (in shares)         4,200,000  
Common stock repurchased (166)       $ (166)  
Excise tax on common stock repurchases (2)       (2)  
Net income 182     182    
Common stock outstanding, ending balance (in shares) at Jul. 01, 2023   252,300,000        
Balance at end of period at Jul. 01, 2023 $ 4,604 $ 3 3,621 1,267 $ (216) (71)
Treasury stock, common, ending balance (in shares) at Jul. 01, 2023         5,500,000  
Common stock outstanding, beginning balance (in shares) at Dec. 30, 2023 245,100,000 252,900,000        
Balance at beginning of period at Dec. 30, 2023 $ 4,749 $ 3 3,663 1,509 $ (311) (115)
Treasury stock, common, beginning balance (in shares) at Dec. 30, 2023 7,800,000       7,800,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense $ 15   15      
Proceeds from employee stock purchase plan (in shares)   100,000        
Proceeds from employee stock purchase plan 5   5      
Vested restricted stock units, net (in shares)   700,000        
Exercise of stock options (in shares)   200,000        
Exercise of stock options 5   5      
Tax withholding payments for net share-settled equity awards (20)   (20)      
Changes in retirement benefit obligations, net of income tax 2         2
Common stock repurchased (in shares)         300,000  
Common stock repurchased (13)       $ (13)  
Net income 82     82    
Common stock outstanding, ending balance (in shares) at Mar. 30, 2024   253,900,000        
Balance at end of period at Mar. 30, 2024 $ 4,825 $ 3 3,668 1,591 $ (324) (113)
Treasury stock, common, ending balance (in shares) at Mar. 30, 2024         8,100,000  
Common stock outstanding, beginning balance (in shares) at Dec. 30, 2023 245,100,000 252,900,000        
Balance at beginning of period at Dec. 30, 2023 $ 4,749 $ 3 3,663 1,509 $ (311) (115)
Treasury stock, common, beginning balance (in shares) at Dec. 30, 2023 7,800,000       7,800,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Changes in retirement benefit obligations, net of income tax $ 3          
Excise tax on common stock repurchases (1)          
Net income $ 280          
Common stock outstanding, ending balance (in shares) at Jun. 29, 2024 245,500,000 254,300,000        
Balance at end of period at Jun. 29, 2024 $ 5,011 $ 3 3,696 1,789 $ (365) (112)
Treasury stock, common, ending balance (in shares) at Jun. 29, 2024 8,800,000       8,800,000  
Common stock outstanding, beginning balance (in shares) at Mar. 30, 2024   253,900,000        
Balance at beginning of period at Mar. 30, 2024 $ 4,825 $ 3 3,668 1,591 $ (324) (113)
Treasury stock, common, beginning balance (in shares) at Mar. 30, 2024         8,100,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense 15   15      
Proceeds from employee stock purchase plan (in shares)   200,000        
Proceeds from employee stock purchase plan 9   9      
Vested restricted stock units, net (in shares)   100,000        
Exercise of stock options (in shares)   100,000        
Exercise of stock options 4   4      
Changes in retirement benefit obligations, net of income tax 1         1
Common stock repurchased (in shares)         700,000  
Common stock repurchased (41)       $ (41)  
Excise tax on common stock repurchases (1)          
Net income $ 198     198    
Common stock outstanding, ending balance (in shares) at Jun. 29, 2024 245,500,000 254,300,000        
Balance at end of period at Jun. 29, 2024 $ 5,011 $ 3 $ 3,696 $ 1,789 $ (365) $ (112)
Treasury stock, common, ending balance (in shares) at Jun. 29, 2024 8,800,000       8,800,000